Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Submitted by
admin
on January 13, 2017 - 11:18am
Source:
Endpoints
News Tags:
Biogen
AstraZeneca
oncology
hemophilia
Bioverativ
Headline:
Biogen spinoff begins trading today; New oncology chief at AstraZeneca
Do Not Allow Advertisers to Use My Personal information